ABBV insider buying & filings

ABBVAbbVie Inc.

NYSE · Healthcare · $467.38B

$261.77

+1.81% · Sep 14

55 insider filings on record.
None of them an open-market buy in the last year.

Last Form 4 Aug 18 · scanned 12m ago

Price · 1Y · daily● 1 sell

▸ hover a marker for the filing · drag to zoom

AI brief · from the filings on this pagePro

The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.

Market cap

$467.38B

Float

1764.0M

100% public

Short % float

Pro

Price / profit

74.5

Price / future profit

16.2

Price / sales

7.3

The record

newest first

DateTypeInsiderOf stakeShares @ priceValue

Aug 18SELLDonoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERdirect32,710 @ $250.00$8.18M

Aug 18EXERCISEDonoghoe NicholasEVP, CHIEF BUS/STRAT OFFICERdirect32,710 @ $79.02$2.58M

Mar 3SELLSiatis Perry CEVP, GC AND SECRETARYdirect2,600 @ $235.26$611.7K

Mar 3SELLSiatis Perry CEVP, GC AND SECRETARYdirect10,291 @ $234.66$2.41M

Mar 3SELLSiatis Perry CEVP, GC AND SECRETARYdirect5,777 @ $233.51$1.35M

The file stays open

▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice